Long-acting injectable formulations have been developed for several peptide drugs, reducing dosing frequency and potentially improving patient adherence
Glycopyrrolate is a quaternary ammonium selective muscarinic antagonist that poorly penetrates the bloodbrain barrier, resulting in predominantly peripheral antimuscarinic activity
This is a core process in the body that affects energy production, detox pathways, neurotransmitter balance, and overall cellular function
Based on previous studies and a review of relevant literature, we hypothesized that SIRT1 is a promising target for GHK-Cu in UC treatment, which will be verified in the subsequent experiments
Cancer Control 1999;6(6):580586
Saatci, O., Kaymak, A., Raza, U., Ersan, P